Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab

被引：0
|
作者：
Bachir, B. [1 ]
Anouti, S. [1 ]
Jaoude, J. Abi [1 ]
Kayali, M. [1 ]
Tfayli, A. [1 ]
De Azambuja, E. [2 ]
Poortmans, P. [3 ]
Zeidan, Y. [1 ,4 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[2] ULB, Brussels, Belgium
[3] Iridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium
[4] Baptist Hlth South Florida, Lynn Canc Inst, Boca Raton, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital
    Ayres, Lorena Rocha
    de Almeida Campos, Marilia Silveira
    Gozzo, Thais de Oliveira
    Martinez, Edson Zangiacomi
    Ungari, Andrea Queiroz
    de Andrade, Jurandyr Moreira
    Leira Pereira, Leonardo Regis
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (02) : 365 - 372
  • [42] Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital
    Lorena Rocha Ayres
    Marília Silveira de Almeida Campos
    Thais de Oliveira Gozzo
    Edson Zangiacomi Martinez
    Andrea Queiróz Ungari
    Jurandyr Moreira de Andrade
    Leonardo Régis Leira Pereira
    International Journal of Clinical Pharmacy, 2015, 37 : 365 - 372
  • [43] Safety and effectiveness of primary systemic therapy with docetaxel and trastuzumab in HER-2 positive breast cancer.
    Griggs, JJ
    Schiffhauer, LM
    Sahasrabudhe, DM
    Pandya, KJ
    Caldwell, C
    Peacock, J
    Messina, P
    Spreng, E
    Bourne, P
    McGuire, GM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 76S - 76S
  • [44] Safety of trastuzumab deruxtecan and radiation therapy combination in HER2-positive metastatic breast cancer patients
    Visani, L.
    Ratosa, I.
    Ribnikar, D.
    Becherini, C.
    Bertini, N.
    Bonaparte, I.
    Stefanovski, D.
    Dobnikar, N.
    Desideri, I.
    Mattioli, C.
    Valzano, M.
    Banini, M.
    Salvestrini, V.
    Bernini, M.
    Tommasi, C.
    Nori, J.
    Orzalesi, L.
    Bianchi, S.
    Livi, L.
    Meattini, I.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 60 - 61
  • [45] Prospective evaluation of atrial function by 2D Speckle Tracking analysis in HER-2 positive breast cancer patients during Trastuzumab therapy
    Setti, E.
    Dolci, G.
    Bergamini, C.
    Schiavone, A.
    Cerrito, L. F.
    Benfari, G.
    Dal Porto, M.
    Comunello, A.
    Bragantini, G.
    Rossi, A.
    Fiorio, E.
    Ribichini, F. L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1426 - 1426
  • [46] PROSPECTIVE EVALUATION OF CIRCULATING BIOMARKERS AS PREDICTORS OF CARDIOTOXICITY IN PATIENTS WITH HER2-POSITIVE BREAST CANCER RECEIVING ANTHRACYCLINES AND TRASTUZUMAB
    Yu, Anthony F.
    Knezevic, Andrea
    Moskowitz, Chaya
    Dang, Chau
    Ramanathan, Lakshmi
    Oeffinger, Kevin
    Liu, Jennifer
    Steingart, Richard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 691 - 691
  • [47] Cardiotoxicity of trastuzumab in the patients with HER2 positive advanced gastric cancer
    Jung, M.
    Park, J. S.
    Lee, C-K.
    Kim, J. H.
    Park, H. S.
    Heo, S. J.
    Beom, S. H.
    Kim, H. S.
    Rha, S. Y.
    Chung, H. C.
    Youn, J-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] A prognostic model to predict the risk of developing brain metastasis in patients treated with trastuzumab for HER-2 positive metastatic breast cancer
    Pansegran, GK
    Lohrisch, CA
    Bajdik, CD
    Speers, CH
    Baerg, BE
    Barnett, JB
    Glemon, KA
    Olivotto, IA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S74 - S74
  • [49] Trastuzumab-induced cardiotoxicity in patients with metastatic HER2-positive breast cancer treated at a reference hospital in Mexico.
    Leocachin-Parra, Daniela Leticia
    Bocardo-Galvan, Jessica Berenice
    Grajales, Rocio
    Carrillo-Estrada, Montserrat
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Cardiotoxicity in HER2-positive breast cancer patients
    Gonciar, Diana
    Mocan, Lucian
    Zlibut, Alexandru
    Mocan, Teodora
    Agoston-Coldea, Lucia
    HEART FAILURE REVIEWS, 2021, 26 (04) : 919 - 935
12345